Camille G Apple1, Elizabeth S Miller1, Tyler J Loftus1, Kolenkode B Kannan1, Hari K Parvataneni2, Jennifer E Hagen2, Philip A Efron1, Alicia M Mohr3. 1. Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida Health, Gainesville, Florida. 2. Department of Orthopedic Surgery, University of Florida, Gainesville, Florida. 3. Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida Health, Gainesville, Florida. Electronic address: alicia.mohr@surgery.ufl.edu.
Abstract
BACKGROUND: Severe traumatic injury is a major cause of morbidity and mortality. Our goal was to analyze blunt traumatic injury by injury severity score (ISS) and compare with elective hip repair, as a transient injury, and healthy control with the hypothesis that more severe injury would lead to an increase in neuroendocrine activation, systemic inflammation, and worse anemia. MATERIALS AND METHODS: A prospective observational cohort study was performed at a level 1 trauma center, comparing blunt trauma patients (n = 37), elective hip replacement patients (n = 26), and healthy controls (n = 8). Bone marrow and plasma were assessed for hyperadrenergic state, erythropoiesis, and systemic inflammation. Trauma patient's ISS ranged from 4 to 41 and were broken down into quartiles for analysis. The ISS quartiles were 4-13, 14-20, 21-26, and 27-41. RESULTS: Plasma norepinephrine, interleukin-6, tumor necrosis factor-alpha, and hepcidin increased progressively as ISS increased. Hemoglobin significantly decreased as ISS increased and packed red blood cell (pRBC) transfusion increased as ISS increased. Elective hip replacement patients had an appropriate increase in the bone marrow expression of erythropoietin and the erythropoietin receptor, which was absent in all trauma patient groups. CONCLUSIONS: Increased neuroendocrine activation, systemic inflammation, and anemia correlated with worsening injury severity, lower age, and increased pRBC transfusions. Elective hip replacement patients have only minimal systemic inflammation with an appropriate bone marrow response to anemia. This study demonstrates a link between injury severity, neuroendocrine activation, systemic inflammation, and the bone marrow response to anemia.
BACKGROUND: Severe traumatic injury is a major cause of morbidity and mortality. Our goal was to analyze blunt traumatic injury by injury severity score (ISS) and compare with elective hip repair, as a transient injury, and healthy control with the hypothesis that more severe injury would lead to an increase in neuroendocrine activation, systemic inflammation, and worse anemia. MATERIALS AND METHODS: A prospective observational cohort study was performed at a level 1 trauma center, comparing blunt traumapatients (n = 37), elective hip replacement patients (n = 26), and healthy controls (n = 8). Bone marrow and plasma were assessed for hyperadrenergic state, erythropoiesis, and systemic inflammation. Traumapatient's ISS ranged from 4 to 41 and were broken down into quartiles for analysis. The ISS quartiles were 4-13, 14-20, 21-26, and 27-41. RESULTS: Plasma norepinephrine, interleukin-6, tumor necrosis factor-alpha, and hepcidin increased progressively as ISS increased. Hemoglobin significantly decreased as ISS increased and packed red blood cell (pRBC) transfusion increased as ISS increased. Elective hip replacement patients had an appropriate increase in the bone marrow expression of erythropoietin and the erythropoietin receptor, which was absent in all traumapatient groups. CONCLUSIONS: Increased neuroendocrine activation, systemic inflammation, and anemia correlated with worsening injury severity, lower age, and increased pRBC transfusions. Elective hip replacement patients have only minimal systemic inflammation with an appropriate bone marrow response to anemia. This study demonstrates a link between injury severity, neuroendocrine activation, systemic inflammation, and the bone marrow response to anemia.
Authors: Angela Penn; Alicia M Mohr; Salil G Shah; Ziad C Sifri; Vicki L Kaiser; Pranela Rameshwar; David H Livingston Journal: J Surg Res Date: 2010-04-18 Impact factor: 2.192
Authors: Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr Journal: Surgery Date: 2015-07-21 Impact factor: 3.982
Authors: Ines G Alamo; Kolenkode B Kannan; Tyler J Loftus; Harry Ramos; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2017-07 Impact factor: 3.313
Authors: Lori F Gentile; Alex G Cuenca; Philip A Efron; Darwin Ang; Azra Bihorac; Bruce A McKinley; Lyle L Moldawer; Frederick A Moore Journal: J Trauma Acute Care Surg Date: 2012-06 Impact factor: 3.313
Authors: Elizabeta Nemeth; Seth Rivera; Victoria Gabayan; Charlotte Keller; Sarah Taudorf; Bente K Pedersen; Tomas Ganz Journal: J Clin Invest Date: 2004-05 Impact factor: 14.808
Authors: Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro Journal: Crit Care Med Date: 2004-01 Impact factor: 7.598
Authors: Camille G Apple; Lauren S Kelly; Kolenkode B Kannan; Ricardo F Ungaro; Frederick A Moore; Scott C Brakenridge; Lyle L Moldawer; Philip A Efron; Alicia M Mohr Journal: Surg Infect (Larchmt) Date: 2021-12-24 Impact factor: 1.853
Authors: Camille G Apple; Elizabeth S Miller; Kolenkode B Kannan; Chase Thompson; Dijoia B Darden; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2021-06-26 Impact factor: 2.192
Authors: Lauren S Kelly; Camille G Apple; Dijoia B Darden; Kolenkode B Kannan; Erick E Pons; Brittany P Fenner; Hari K Parvataneni; Jennifer E Hagen; Scott C Brakenridge; Philip A Efron; Alicia M Mohr Journal: Shock Date: 2022-01-01 Impact factor: 3.454